Mode
Text Size
Log in / Sign up
N/A Completed N=104

Multidisciplinary Evaluation of Patients With Hemophilia

Haemophilia
Source: ClinicalTrials.gov NCT02198430 ↗
Enrolled (actual)
104
Serious AEs
Results posted
Oct 2016
Primary outcomePrimary: Assess the Joint Damage — 0.36; 0 points

Summary

Multidisciplinary assessment of the physical, functional and psychosocial alterations in patients with hemophilia around the country. The aims of this study are: * Descriptive study of joint involvement in hemophilia patients with and without a history of hemarthrosis. * Descriptive study of the alterations of periarticular muscle strength as a result of acute processes or the development of chronic articular sequelae. * Descriptive study of biomechanical changes in lower limb joints and their impact on gait in patients with hemophilia. * Descriptive study of the joint space, regarding hemarthrosis and synovitis, intraarticular by ultrasonography. * Descriptive study of the relationship between skeletal muscle pathology in patients with hemophilia and their perceptions of it and their quality of life.

Outcome Measures

OutcomeResultp-value
PRIMARY
Assess the Joint Damage
0.36; 0
PRIMARY
Assess the Perception of Quality of Life
38.32; 37.55
SECONDARY
Assessment of Clinical Patient Variables
92.5; 0
SECONDARY
Measure of Weight
41.59; 39.36

Eligibility Criteria

Inclusion Criteria

  • Patients with hemophilia A and B.
  • Patients of all ages (pediatric, adolescents, youth and adults).
  • With or without joint involvement clinically diagnosed, and with or without a previous history of hemarthrosis joint loading.
  • Patients with or without inhibitors.

Exclusion Criteria

  • Patients without prior walking capacity.
  • Patients diagnosed with other congenital coagulopathy (von Willebrand disease, etc..).
  • Patients with neurological or cognitive impairments that prevent understanding the questionnaires and physical tests.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02198430). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search